Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Buffett's Berkshire invests in four big drugmakers

Published 16/11/2020, 21:56
Updated 16/11/2020, 22:01
© Reuters.

© Reuters.

(Reuters) - Warren Buffett's Berkshire Hathaway Inc (N:BRKa) said on Monday it has begun investing in the stocks of four large drugmakers.

In a regulatory filing detailing its U.S.-listed investments as of Sept. 30, Berkshire disclosed new stakes in Abbvie Inc (N:ABBV), Bristol-Myers Squibb Co (N:BMY) and Merck & Co (N:MRK) of more than $1.8 billion (£1.3 billion) each, and a new $136 million stake in Pfizer Inc (N:PFE).

Investors monitor Omaha, Nebraska-based Berkshire's quarterly filings to see where Buffett and his portfolio managers Todd Combs and Ted Weschler see value.

Shares of the four drugmakers rose in after-hours trading, which often occurs when Berkshire discloses new investments, reflecting what investors view as Buffett's imprimatur.

Berkshire did not say whether Buffett made the investments, though larger investments are normally his.

The investments look similar to the multi-billion dollar stakes that Berkshire recently maintained in the four largest U.S. airlines, before selling them in April amidst the coronavirus pandemic.

© Reuters. Warren Buffett, CEO of Berkshire Hathaway Inc, pauses while playing bridge as part of the company annual meeting weekend in Omaha

In Monday's filing, Berkshire also revealed a new $276 million stake in wireless phone company T-Mobile US Inc (O:TMUS).

Latest comments

He must be averaging
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.